Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.
about
Distribution of estrogen and progesterone receptors isoforms in endometrial cancer.Clinical significance of COX-2, GLUT-1 and VEGF expressions in endometrial cancer tissuesPredicting malignant transformation of esophageal squamous cell lesions by combined biomarkers in an endoscopic screening program.Evaluation of the Pathogenesis of Tumor Development from Endometriosis by Estrogen Receptor, P53 and Bcl-2 Immunohistochemical StainingMyoferlin Expression and Its Correlation with FIGO Histologic Grading in Early-Stage Endometrioid Carcinoma.
P2860
Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Utility of Ki-67, p53, Bcl-2, ...... dometrium by imprint cytology.
@en
Utility of Ki-67, p53, Bcl-2, ...... dometrium by imprint cytology.
@nl
type
label
Utility of Ki-67, p53, Bcl-2, ...... dometrium by imprint cytology.
@en
Utility of Ki-67, p53, Bcl-2, ...... dometrium by imprint cytology.
@nl
prefLabel
Utility of Ki-67, p53, Bcl-2, ...... dometrium by imprint cytology.
@en
Utility of Ki-67, p53, Bcl-2, ...... dometrium by imprint cytology.
@nl
P2093
P2860
P356
P1476
Utility of Ki-67, p53, Bcl-2, ...... dometrium by imprint cytology.
@en
P2093
Efstratios Patsouris
George Apostolou
Maria Biteli
Nicolaos Apostolou
Nikolaos Kavantzas
Paulina Athanassiadou
P2860
P304
P356
10.1002/DC.23010
P577
2013-06-01T00:00:00Z